My Account
Follow us on:
Powered By
See the top gainers, losers, invest and get updated what's happening in the crypto market
Invest Now
Discover the secret world of unlisted shares — analyse India's top pre-IPO companies and invest before they hit the markets
Firstcall Research is bullish on Nectar Lifesciences and has recommended buy rating on the stock with a target of Rs 46 in its October 29, 2014 research report.
You are already a Moneycontrol Pro user.